Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway

Jie Huang, Xiaoling Fu, Qiang Xue, Peng Ma, Yating Yin, Minjie Jiang, Yunpeng Lu, Qi Ying, Jun Jiang, Hua He, Da Wu

Open source

DOI
10.1155/2023/7146589
Published
2023-02-18
Container
Disease Markers
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2023/7146589,
  title = {Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway},
  author = {Jie Huang and Xiaoling Fu and Qiang Xue and Peng Ma and Yating Yin and Minjie Jiang and Yunpeng Lu and Qi Ying and Jun Jiang and Hua He and Da Wu},
  year = {2023},
  journal = {Disease Markers},
  doi = {10.1155/2023/7146589},
  url = {https://doi.org/10.1155/2023/7146589}
}

RIS

TY  - JOUR
TI  - Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway
AU  - Jie Huang
AU  - Xiaoling Fu
AU  - Qiang Xue
AU  - Peng Ma
AU  - Yating Yin
AU  - Minjie Jiang
AU  - Yunpeng Lu
AU  - Qi Ying
AU  - Jun Jiang
AU  - Hua He
AU  - Da Wu
PY  - 2023
JO  - Disease Markers
DO  - 10.1155/2023/7146589
UR  - https://doi.org/10.1155/2023/7146589
ER  - 

APA

Huang, J., Fu, X., Xue, Q., Ma, P., Yin, Y., Jiang, M., Lu, Y., Ying, Q., Jiang, J., He, H., & Wu, D. (2023). Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway. Disease Markers. https://doi.org/10.1155/2023/7146589

Source records